National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

About | Ordering | New

Menu menu

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$39.00
add to cart

Rights & Permissions

topleft topright

Immunization Safety Review: Vaccines and Autism (2004)
Board on Health Promotion and Disease Prevention (HPDP)
 Institute of Medicine (IOM)

Citation Manager

. "Appendix C: Thimerosal Content in Licensed Vaccines." Immunization Safety Review: Vaccines and Autism. Washington, DC: The National Academies Press, 2004.

Please select a format:

BibTeX EndNote RefMan
Page
185
bottomleft bottomright
  E-mail
Share on facebook Facebook
Share on delicious Delicious
Share on stumbleupon Stumble
Share on twitter Twitter
More Sharing ServicesMore

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.

Immunization Safety Review: Vaccines and Autism

TABLE C-2 Mercury Content from Thimerosal in the Currently Licensed Vaccines That Are Recommended for Some Children in the United States, April 2004

Vaccine

Brand Name

Manufacturer

Hg [μg/dose]

DT

(Diphtheria and tetanus toxoids)

All Products

Aventis Pasteur, Inc. (single dose)

0.3

 

Aventis Pasteur, Inc. (multi-dose)

25

 

Aventis Pasteur, Ltd*

25

TT (Tetanus Toxoid)

All Products

Aventis Pasteur, Inc.

25

Pneumococcal Polysaccharide

Pneumovax 23

Merck

0

Hepatitis A

Havrix

Glaxo-SmithKline

0

Vaqta

Merck

0

Influenza

Fluzone1

Aventis Pasteur, Inc.

25

Fluzone

(Preservative free)

Aventis Pasteur, Inc.

≤1 μg/0.5 mL

dose or ≤0.5 μg/

0.25 mL dose

Fluvirin

Evans

25

Fluvirin

Evans

<1 μg

Influenza, Live

FluMist

MedImmune

0

*Not available in the United States.

1Children under 3 years of age received half of a vaccine dose (0.25 mL or 12.5 μg mercury/dose).
Page
185